Organisation paid for research Program year 2025 Source: CMS Open Payments

Sentara Hospitals

Neither a doctor nor a teaching hospital

Research payments

$322,912

105 payments

Through program year 2025, Sentara Hospitals is reported as receiving $322,912 in research payments, across 105 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$97,727	23
2024	Research	$47,646	20
2023	Research	$96,393	45
2022	Research	$44,812	15
2021	Research	$3,593	1
2020	Research	$32,742	1

Breakdown

Who paid Research payments · program years 2020–2025

Inari Medical, Inc. $84,762 43 payments
Bayer HealthCare Pharmaceuticals Inc. $79,624 34 payments
Penumbra, Inc. $39,009 16 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $32,742 1 payment
Philips Electronics North America Corporation $26,276 5 payments
Ucb SA $22,334 2 payments
Medtronic, Inc. $19,492 3 payments
Stryker Corporation $18,674 1 payment

Studies the money was for Research payments · program years 2020–2025

BAY94-8862 LCM HFmr/pEF (EF 40%) $38,065 17 payments
RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis (DEFIANCE) $33,046 2 payments
Safety & Efficacy of Empa in patients with Acute H $32,742 1 payment
Strike-Pe $28,635 11 payments
Thor Ide $26,276 5 payments
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia $22,881 4 payments
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LV $21,957 3 payments
Alleviate-Hf $19,492 3 payments
A Patient- and Investigator-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Bepranemab (Ucb0107) in Study Participants With Prodromal to Mild Alzheimer's Disease (Ad), Followed By An Open-Label Extension Period $19,100 1 payment
FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) $18,880 24 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.